U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
191641191641Study Evaluating Venlafaxine ER in Adults With Panic DisorderCompletedNo Results AvailablePanic DisorderDrug: Venlafaxine ERhttps://ClinicalTrials.gov/show/NCT00038896
191642191642Campath-1H and Allogeneic Blood Stem Cell Transplantation for Lymphoid MalignanciesCompletedNo Results AvailableLeukemia, Lymphocytic, Chronic|Leukemia, Lymphocytic, Acute|Lymphoma, Low-Grade|Lymphoma, T-Cell|Lymphoma, B-CellDrug: Campath-1Hhttps://ClinicalTrials.gov/show/NCT00038883
191643191643Therapy of Relapsed AML With Chemotherapy and Dendritic Cell Activated LymphocytesWithdrawnNo Results AvailableAcute Myelogenous Leukemia|Chronic Myelogenous LeukemiaBiological: Dendritic Cell Activated Lymphocytehttps://ClinicalTrials.gov/show/NCT00038870
191644191644Megadose CD34 Selected Progenitor Cells for Transplantation in Patients With Advanced Hematological Malignant DiseasesCompletedHas ResultsLeukemia|LymphomaProcedure: Megadose of CD34 Selected Progenitor Cells|Drug: Melphalan|Drug: Thiotepa|Drug: Fludarabine|Drug: Rabbit ATGhttps://ClinicalTrials.gov/show/NCT00038857
191645191645Safety and Efficacy of Campath in Nonmyeloablative TransplantationCompletedNo Results AvailableLymphoma|LeukemiaDrug: Campath-1 H (Alemtuzumab)|Drug: Fludarabine|Drug: Cyclophosphamide|Drug: Rituximabhttps://ClinicalTrials.gov/show/NCT00038844
191646191646Allo Transplantation With Mylotarg, Fludarabine and Melphalan for AML, CML and MDSCompletedNo Results AvailableAcute Myelogenous Leukemia|Myelodysplastic Syndrome|Chronic Lymphocytic LeukemiaDrug: Mylotarg|Drug: Fludarabine|Drug: Melphalan|Drug: Anti-thymocyte globulin|Procedure: Stem cell transplanthttps://ClinicalTrials.gov/show/NCT00038831
191647191647CD8 DLI for Patients With Relapse or Residual Disease Following Allogeneic Stem Cell TransplantationTerminatedNo Results AvailableChronic Myelogenous Leukemia|Multiple Myeloma|Non Hodgkin's Lymphoma|Hodgkin's Disease|Chronic Lymphocytic LeukemiaBiological: CD8 Depleted Donor Lymphocytehttps://ClinicalTrials.gov/show/NCT00038818
191648191648Nonmyeloablative Preparative Regimen Using Mylotarg for Patients With High Risk Acute Myeloid Leukemia (AML), Acute Lymphocytic Leukemia (ALL), Chronic Myeloid Leukemia (CML) and Myelodysplastic Syndrome (MDS)TerminatedNo Results AvailableLeukemiaDrug: Mylotarghttps://ClinicalTrials.gov/show/NCT00038805
191649191649Phase I/II Trial rHuKFG for the Treatment of Steroid Refractory Gastrointestinal Acute GVHDTerminatedNo Results AvailableAcute Graft Versus Host DiseaseDrug: Recombinant Human Keratinocyte Growth Factorhttps://ClinicalTrials.gov/show/NCT00038792
191650191650Blood Transplantation for Patients With Hematologic Malignancies or Bone Marrow Failure StatesTerminatedNo Results AvailableLeukemia|Non Hodgkin's Lymphoma|Aplastic AnemiaProcedure: Megadose T-cell Depleted HLA-nonidentical Blood Progenitor Cell Transplantationhttps://ClinicalTrials.gov/show/NCT00038779
191651191651CNI-1493 for Treatment of Moderate to Severe Crohn's DiseaseTerminatedNo Results AvailableCrohn DiseaseDrug: semapimod|Drug: semapimod|Drug: placebohttps://ClinicalTrials.gov/show/NCT00038766
191652191652Vision In Preschoolers Study (VIP Study)Active, not recruitingNo Results AvailableAmblyopia|Strabismus|Refractive ErrorProcedure: Vision Screeninghttps://ClinicalTrials.gov/show/NCT00038753
191653191653Diabetes Prevention Program Outcomes StudyActive, not recruitingNo Results AvailableDiabetes MellitusBehavioral: Group Lifestyle|Drug: Metformin|Behavioral: Boost Lifestylehttps://ClinicalTrials.gov/show/NCT00038727
191654191654A Trial Study of SGN-00101 in Treating Pediatric Patients With Recurrent Respiratory PapillomatosisCompletedNo Results AvailablePapilloma|Recurrent Respiratory PapillomatosisDrug: SGN-00101https://ClinicalTrials.gov/show/NCT00038714
191655191655Study of Gemcitabine Chemoradiation and TNP-470 Patients Locally Advanced, Nonmetastatic Adenocarcinoma of PancreasTerminatedNo Results AvailablePancreatic NeoplasmsDrug: TNP-470https://ClinicalTrials.gov/show/NCT00038701
191656191656A Study of Peer Education to Prevent HIV Transmission Among Injection Drug Users and Their HIV Risk ContactsCompletedNo Results AvailableHIV InfectionsBehavioral: Peer HIV Education Programhttps://ClinicalTrials.gov/show/NCT00038688
191657191657Therapy of HES, PV, Atypical Chronic Myelocytic Leukemia (CML) or Chronic Myelomonocytic Leukemia (CMML), and Mastocytosis With Imatinib MesylateCompletedNo Results AvailableChronic Myelomonocytic Leukemia|Chronic Myeloid Leukemia|Polycythemia Vera|Hypereosinophilic Syndrome|MastocytosisDrug: Imatinib Mesylate (Gleevec)https://ClinicalTrials.gov/show/NCT00038675
191658191658Safety and Efficacy of Atrasentan in Men With Hormone Naive Prostate Cancer Exhibiting Early Signs of Biochemical FailureCompletedNo Results AvailableProstatic NeoplasmsDrug: Atrasentanhttps://ClinicalTrials.gov/show/NCT00038662
191659191659Therapy of Early Chronic Phase CML With Higher-Dose Gleevec, Alpha Interferon, and Low-Dose Ara-CTerminatedNo Results AvailableMyelogenous Leukemia, Chronic, Chronic PhaseDrug: Gleevechttps://ClinicalTrials.gov/show/NCT00038649
191660191660A Study of Two Different Doses of ABT-378/Ritonavir in HIV-Infected Patients Who Have Taken Protease Inhibitors and Non-Nucleoside Reverse Transcriptase InhibitorsCompletedNo Results AvailableHIV InfectionsDrug: Lopinavir/ritonavir|Drug: Ritonavirhttps://ClinicalTrials.gov/show/NCT00038636
191661191661Study Of Yttrium-ibritumomab (Zevalin) For the Treatment Of Patients With Relapsed And Refractory Mantle Cell LymphomaCompletedNo Results AvailableLymphoma, Mantle-CellDrug: Yttrium-ibritumomab (Zevalin)|Drug: Rituximabhttps://ClinicalTrials.gov/show/NCT00038623
191662191662Study of Hyper-CVAD Plus Imatinib Mesylate for Philadelphia-Positive Acute Lymphocytic LeukemiaCompletedHas ResultsLeukemiaDrug: Imatinib Mesylate|Drug: Cyclophosphamide|Drug: Doxorubicin|Drug: Vincristine|Drug: Dexamethasone|Drug: Methotrexate|Drug: Cytarabine|Drug: Mesna|Drug: G-CSFhttps://ClinicalTrials.gov/show/NCT00038610
191663191663Phase II Study of SCH66336, A Farnesyltransferase Inhibitor in Chronic Myelogenous Leukemia (CML)CompletedNo Results AvailableMyelogenous Leukemia, ChronicDrug: SCH66336https://ClinicalTrials.gov/show/NCT00038597
191664191664A Phase IB Study Of Oral SCH 66336 Preoperatively In Patients With Head And Neck Squamous Cell CancerCompletedNo Results AvailableCarcinoma, Squamous Cell|Cancer of Head and NeckDrug: SCH66336https://ClinicalTrials.gov/show/NCT00038584
191665191665Proteasome Inhibitor PS-341 Relapsed or Refractory B Cell Lymphomas Previously Treated With ChemotherapyCompletedNo Results AvailableLymphoma, B-CellDrug: PS341 (Bortezomib)https://ClinicalTrials.gov/show/NCT00038571
191666191666Prophylactic Use of Filgrastim SD/01 in Patients With Hodgkin's Disease Receiving ABVD ChemotherapyCompletedNo Results AvailableHodgkin DiseaseDrug: Filgrastim SD/01|Drug: Adriamycin|Drug: Bleomycin|Drug: Vinblastine|Drug: DTIChttps://ClinicalTrials.gov/show/NCT00038558
191667191667A Phase II Study of Paclitaxel and Topotecan With Filgrastim-SD/01 Support For Relapsed and Refractory Aggressive Non-Hodgkin's LymphomaCompletedNo Results AvailableNon-Hodgkin's LymphomaDrug: Filgrastim SD/01|Drug: Paclitaxel|Drug: Topotecanhttps://ClinicalTrials.gov/show/NCT00038545
191668191668Amprenavir/Ritonavir, Saquinavir/Ritonavir or Efavirenz in HIV-Infected Subjects Following Failure With Kaletra (ABT-378/Ritonavir) as Their First Protease Inhibitor Based HAARTCompletedNo Results AvailableHIV InfectionsDrug: Amprenavir/ritonavir|Drug: Saquinavir/ritonavir|Drug: Efavirenzhttps://ClinicalTrials.gov/show/NCT00038532
191669191669Amprenavir/Ritonavir or Saquinavir/Ritonavir in HIV-Infected Subjects Following Failure With Kaletra as Their Second Protease InhibitorCompletedNo Results AvailableHIV InfectionsDrug: Amprenavir/ritonavir|Drug: Saquinavir/ritonavirhttps://ClinicalTrials.gov/show/NCT00038519
191670191670Study Of Investigational Regimen Combining FDA Approved HIV Drugs In HIV Subjects Experiencing Early Virologic FailureCompletedNo Results AvailableHIV InfectionDrug: abacavir/lamivudine/zidovudine|Drug: tenofovirhttps://ClinicalTrials.gov/show/NCT00038506

* Görseller ve İçerik tekif hakkına sahip olabilir